Related Experiment Video
Updated: Jan 21, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population
Kim Pauwels1, Isabelle Huys1, Minne Casteels1
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, P.O. Box 521, Onderwijs en Navorsing 2, Herestraat 49, 3000, Leuven, Belgium.
Background:
Debate on pricing and reimbursement of cancer medicines highlights the need to establish the value of cancer medicines.
Objective:
This study aims to elicit the trade-offs in cancer medicine characteristics that the Belgian population is willing to make.
Methods:
A discrete choice experiment used six attributes with three levels each, based on literature and focus group discussions. The survey was sent to a random sample of 3500 Belgian citizens. Based on the choice of 961 respondents, individual parameters were estimated with a mixed logit model.
Results:
Societal value of cancer medicines was positively affected by a higher number of patients eligible for treatment, a high initial life expectancy and quality of life of patients, a high gain in quality of life and life expectancy due to treatment, and a low treatment cost. The value of 1-year gain in life expectancy was independent from the initial life expectancy of the patient. However, the value of one-point gain in quality of life was higher for patients with a low initial quality of life than for patients with a high initial quality of life.
Conclusions:
This study has shown that gain in quality of life with cancer medicines is valued higher by Belgian society for patients who have lower initial quality of life before the start of treatment.
More Related Videos
Related Concept Videos
Discrete Fourier Transform
Population Growth
Conservation of Small Populations
Mate Choice
Discrete-time Fourier transform
One of the notable...
What is Population Genetics?

